CS
Chris Schott JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
9.7%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
70%
Neutral
20%
Negative
10%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $35 |
10%
upside
| 2 | +17% |
0
%
| 16 Dec ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $18 |
20%
upside
| 2 | -36% |
0
%
| 15 Dec ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $1,150 |
11%
upside
| 1 | +18% |
0
%
| 18 Nov ‘25 2 months ago |
|
|
|
Underweight
Maintained
| $12 |
37%
upside
| 1 | -14% |
0
%
| 11 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $200 |
60%
upside
| 1 | +0.15% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $775 |
8%
upside
| 1 | +17% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $260 |
21%
upside
| 1 | -0.75% |
0
%
| 3 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $150 |
20%
upside
| 1 | +6% |
0
%
| 31 Oct ‘25 2 months ago |
|